Pharmaceutical Companies Developing 270 New Vaccines

The share of biologic-based drugs in the global pharmaceutical market is rising, with more and more products, especially vaccines, emerging from research and development efforts. A driving factor in biologic sector growth is drug company confidence that bigger revenue will be realized from the push to market. As of February 7, 2013, there were 907 biopharmaceuticals in Phase I, II or III development, or under regulatory review, according to a report released by Pharmaceutical Research and Manufacturers of America (PhRMA)

Read more here: Pharmaceutical Companies Developing 270 New Vaccines

Please follow and like us:

Related Post

Leave a Reply